
Commentary|Videos|June 2, 2025
ASCO 2025: Top Data Highlights from 6/2
Author(s)Yan Leyfman, MD, Chandler Park, MD, MSc, FACP
Fact checked by: Kristi Rosa
MedNews Week hosts speak with 8 key opinion leaders at ASCO 2025 about the top data highlights of the day.
Advertisement
On the Clock is a dynamic video series from MedNews Week and OncLive, bringing you rapid-fire insights from top oncology experts at the 2025 ASCO Annual Meeting. In each episode, key opinion leaders share the data they’re most excited about—highlighting the studies, trends, and breakthroughs that could shape clinical practice.
In this episode, hosts Chandler Park, MD, FACP, and Yan Leyfman, MD, spoke with the following key opinion leaders:
- Liz O'Riordan, MD, PhD, FRCS, of Royal Marsden Hospital
- Laila Agrawal, MD, of Norton Cancer Institute
- Debora Barton, MD, of Full-Life Technologies
- Arya Roy, MD, of The Ohio State University Comprehensive Cancer Center–The James
- Kevin Kayvan Zarrabi, MD, MS, FACP, of Sidney Kimmel Comprehensive Cancer Center
- Pashtoon Kasi, MD, MS, of City of Hope
- Ann LaCasce, MD, MMSc, of Dana-Farber Cancer Institute
- Nina Shah, MD, of UCSF Health and AstraZeneca
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Nivolumab Plus SOC Therapy Shows Encouraging Disease Control in Grade Group 5 Prostate Cancer
2
Capivasertib/Fulvestrant Yields Numerical OS Advantage in PIK3CA/AKT1/PTEN–Altered Breast Cancer
3
Post–T-DXd Sacituzumab Govitecan Plus Trastuzumab Yields Low ORR in HER2+ Metastatic Breast Cancer
4
ADCs Reshape the Future of Lung Cancer Care: From Second-Line Therapy to Earlier Intervention
5




















































